Recent data confirm that sGC stimulation may protect against organ injury independently of its effects on vascular tone: at a dose below that affecting blood pressure, BAY 41-2272 still attenuated cardiac fibrosis in rodent models of hypertension induced by infusion of angiotensin II [39] and suprarenal aortic constriction [40]. Here, SGCB is linked to hypertensive disorder.